Hugtenburg JG - Search Results

1

Patient satisfaction with information on oral anticancer agent use.

Boons CCLM, Timmers L, van Schoor NM, Swart EL, Hendrikse NH, Janssen JJWM, Hugtenburg JG. Boons CCLM, et al. Among authors: hugtenburg jg. Cancer Med. 2018 Jan;7(1):219-228. doi: 10.1002/cam4.1239. Epub 2017 Nov 23. Cancer Med. 2018. PMID: 29168352 Free PMC article.

2

Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method.

van Leeuwen RW, Swart EL, Boom FA, Schuitenmaker MS, Hugtenburg JG. van Leeuwen RW, et al. Among authors: hugtenburg jg. BMC Cancer. 2010 Dec 13;10:679. doi: 10.1186/1471-2407-10-679. BMC Cancer. 2010. PMID: 21144049 Free PMC article.

3

Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method.

van Leeuwen RW, Swart EL, Boven E, Boom FA, Schuitenmaker MG, Hugtenburg JG. van Leeuwen RW, et al. Among authors: hugtenburg jg. Ann Oncol. 2011 Oct;22(10):2334-41. doi: 10.1093/annonc/mdq761. Epub 2011 Feb 22. Ann Oncol. 2011. PMID: 21343376 Free article.

4

The use of erlotinib in daily practice: a study on adherence and patients' experiences.

Timmers L, Boons CC, Mangnus D, Moes JE, Swart EL, Boven E, Smit EF, Hugtenburg JG. Timmers L, et al. Among authors: hugtenburg jg. BMC Cancer. 2011 Jul 1;11:284. doi: 10.1186/1471-2407-11-284. BMC Cancer. 2011. PMID: 21722354 Free PMC article.

5

Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008.

Timmers L, Beckeringh JJ, van Herk-Sukel MP, Boven E, Hugtenburg JG. Timmers L, et al. Among authors: hugtenburg jg. Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1036-44. doi: 10.1002/pds.2225. Epub 2011 Sep 29. Pharmacoepidemiol Drug Saf. 2012. PMID: 21956857

6

The use of capecitabine in daily practice: a study on adherence and patients' experiences.

Timmers L, Swart EL, Boons CC, Mangnus D, van de Ven PM, Peters GJ, Boven E, Hugtenburg JG. Timmers L, et al. Among authors: hugtenburg jg. Patient Prefer Adherence. 2012;6:741-8. doi: 10.2147/PPA.S36757. Epub 2012 Oct 19. Patient Prefer Adherence. 2012. PMID: 23118530 Free PMC article.

7

Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions.

Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Hugtenburg JG, et al. Patient Prefer Adherence. 2013 Jul 10;7:675-82. doi: 10.2147/PPA.S29549. Print 2013. Patient Prefer Adherence. 2013. PMID: 23874088 Free PMC article.

8

The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.

Boons CC, VAN Tulder MW, Burgers JA, Beckeringh JJ, Wagner C, Hugtenburg JG. Boons CC, et al. Among authors: hugtenburg jg. Anticancer Res. 2013 Sep;33(9):3553-61. Anticancer Res. 2013. PMID: 24023280 Review.

9

Adherence and patients' experiences with the use of oral anticancer agents.

Timmers L, Boons CC, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JN, Boven E, Hugtenburg JG. Timmers L, et al. Among authors: hugtenburg jg. Acta Oncol. 2014 Feb;53(2):259-67. doi: 10.3109/0284186X.2013.844353. Epub 2013 Nov 22. Acta Oncol. 2014. PMID: 24266637

10

Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.

Boons CC, Swart EL, Timmers L, van de Ven PM, Janssen JJ, Hugtenburg JG. Boons CC, et al. Among authors: hugtenburg jg. BMC Cancer. 2014 Apr 8;14:247. doi: 10.1186/1471-2407-14-247. BMC Cancer. 2014. PMID: 24712728 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters